Artificial Cornea and Corneal Implants Market to grow at an Impressive CAGR During the Forecast Period
Increasing
prevalence of ophthalmic diseases is supporting the growth of Global Artificial
Cornea and Corneal Implants Market.
According to TechSci Research report, “Global Artificial
Cornea and Corneal Implants Market By Type (Human Cornea
v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s
Endothelial Keratoplasty) By Disease Indication (Fuchs’
Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals,
Ambulatory Care Centers, Others) By Region, Competition Forecast &
Opportunities, 2026”, the global artificial
cornea and corneal implants market is anticipated to show robust growth in the
upcoming five years owing to the major factors like rising population of the
old people. Older population have a tendency of contracting various high-risk
eye diseases, also vision impairment and corneal rupture is quite frequent in
the geriatric population, supporting the growth of global artificial cornea and
corneal implants market in the next five years.
Moreover, organizations like Eye Bank Association of America (EBAA) and
The Global Alliance of Eye Bank Associations are creating a lot of awareness
and are promoting policies regarding effective corneal transplantation and
encouraging the patients to choose the procedure. This factor is actively
supporting the global artificial cornea and corneal implants market growth in
the next five years. Additionally, the market experiences a surge in demand of
non-invasive or minimally invasive procedure for various medical diagnostic and
surgical requirements thereby boosting the growth of global artificial cornea and
corneal implants market from 2022 to 2026.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Artificial Cornea and Corneal
Implants Market"
https://www.techsciresearch.com/report/artificial-cornea-and-corneal-implants-market/7608.html
The global artificial cornea and corneal implants market is segmented by
type, transplantation type, disease indication, end user, competitional
landscape and regional distribution. Based on transplantation type the market
is further segmented into penetrating keratoplasty v/s endothelial keratoplasty.
Penetrating keratoplasty is the dominant market segment with the largest shares
in the historical period. Penetrating keratoplasty is also anticipated to
assert its dominance over the market in the upcoming five years, owing its
growth to the safety and efficiency of the procedure. Although the market
segment faces a minor threat from its alternate procedure; endothelial
keratoplasty. Endothelial keratoplasty is anticipated to record fastest growth
in the upcoming market owing its growth to the promising results the procedure
shows. The endothelial keratoplasty is the latest approach in the market and
involves minimal invasion like it only replaces the affected tissue rather than
the complete cornea. Availability of the human cornea for the replacement is an
issue that becomes null and void because of the efficiency of the endothelial
keratoplasty procedure. Moreover, the procedure helps with the faster and
better visual restoration with decreased risk of eye infection and any pother
accidental mishaps during procedure. Also, growing prevalence of Fuchs
dystrophy is anticipated to support the robust growth of the market segment.
Based on disease indication, the market is further bifurcated into Fuchs’
dystrophy, keratoconus, fungal keratitis, and others. Rising geriatric
population is quite susceptible to contracting Fuchs’ dystrophy. The disease
held the largest as well as the fastest growing market share. It is anticipated
to assert its dominance in the forecast period too. Keratoconus disease held
the significant share of market too, rising number of the patient suffering
from keratoconus often reach the stage where they require corneal implant to
regain their normal vision. Advanced procedures like Deep Anterior Lamellar
Keratoplasty (DALK) bestows the advantage, the factor, along with FDA approved
corneal implants are major drivers of the market growth in the forecast period.
Top players of the market are F. Hoffmann-La Roche Ltd, Regeneron
Pharmaceuticals, Inc, Alcon, Inc., Bayer AG, Bausch & Lomb Incorporated,
AJL Ophthalmic S.A., CorneaGen Inc., Addition Technology, Inc., LinkoCare Life
Sciences AB, Presbia plc, Mediphacos, Aurolab (Aravind Eye Care System), LinCor
Biosciences, Pte. Ltd. (Cornea Biosciences), DIOPTEX GmbH, EyeYon Medical
Ltd.., among others. Other strategies include partnerships among the players
and technologically advanced product launches.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7608
Customers can also request for
10% free customization on this report.
“Major players of the
market are headquartered in the North American region. The efficient
reimbursement policies by the government of large economies like United States
in the region, make North America the dominating sector for the market.
Moreover, the players are actively involved in the research and development of
the implants and efficient processes thereby supporting the market growth in
the forecast period. Asia Pacific region is expected to be fastest growing
market. New markets in the developing countries are emerging and the cost
effective procedures in these countries would help strengthen the market in
countries like China, Indonesia, Philippines,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based Global management consulting
firm.
“Global Artificial Cornea
and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By
Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By
Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By
End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition
Forecast & Opportunities, 2026”, has evaluated the future growth potential
of global artificial cornea and corneal implants and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in global artificial cornea and corneal implants.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/